Market Cap 472.61M
Revenue (ttm) 240,000.00
Net Income (ttm) -64.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26,675.00%
Debt to Equity Ratio 0.00
Volume 2,294,876
Avg Vol 2,388,266
Day's Range N/A - N/A
Shares Out 89.00M
Stochastic %K 74%
Beta 0.89
Analysts Strong Sell
Price Target $20.17

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitiv...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
Unknown_Stuntman
Unknown_Stuntman Jul. 7 at 4:53 PM
$ATYR wild volatility today
0 · Reply
Pratik2024
Pratik2024 Jul. 7 at 1:32 PM
$ATYR $GOOS $MWYN $PUBM $WRBY Good morning
0 · Reply
BioBingo
BioBingo Jul. 7 at 1:10 PM
$ATYR – What’s On This Week: Options Expiry Approaches, “Lab Conditions” Continue, and the Three-Month Countdown We’re entering the first full trading week of July, with $ATYR now within the three-month window for the pivotal Phase 3 efzofitimod readout. This week is shaping up as classic “lab conditions”: no major news, low volatility, and a calm tape post-Russell rebalance. Next short interest report drops later this week; options expiry (July 18) is fast approaching and could drive near-term positioning and volatility. Retail sentiment and engagement remain high. In my view, there’s no new info to change anyone’s core thesis—this is a period to observe, recalibrate, and prep for what’s ahead. Full long-form breakdown here: https://www.reddit.com/r/ATYR_Alpha/s/CjDzvXXBfh
0 · Reply
lola269
lola269 Jul. 7 at 12:17 PM
0 · Reply
bob397
bob397 Jul. 5 at 3:54 PM
1 · Reply
bob397
bob397 Jul. 5 at 3:52 PM
0 · Reply
xersdave
xersdave Jul. 5 at 12:54 PM
$ATYR Gimme that E-$40. SPRINKLE me.
0 · Reply
Passaten
Passaten Jul. 3 at 8:10 PM
$ATYR considering how much of the shares are locked up, this stock is one of the easiest right now to “press button, get money” 😂 just gotta be careful
0 · Reply
Unknown_Stuntman
Unknown_Stuntman Jul. 3 at 7:04 PM
$ATYR who would have thought this would turn into such a profitable day trade vehicle?
1 · Reply
RICARDO34
RICARDO34 Jul. 3 at 4:13 PM
$ATYR under accumulation at these levels. very promising
0 · Reply
Latest News on ATYR
aTyr Pharma to Present at Upcoming Investor Conferences

May 20, 2025, 8:00 AM EDT - 6 weeks ago

aTyr Pharma to Present at Upcoming Investor Conferences


aTyr Pharma to Participate in April Investor Conferences

Apr 3, 2025, 8:00 AM EDT - 3 months ago

aTyr Pharma to Participate in April Investor Conferences


aTyr Pharma, Inc. (ATYR) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 11:18 PM EDT - 4 months ago

aTyr Pharma, Inc. (ATYR) Q4 2024 Earnings Call Transcript


aTyr Pharma: The Bull Has Finally Come Out

Oct 24, 2024, 1:00 PM EDT - 9 months ago

aTyr Pharma: The Bull Has Finally Come Out


aTyr Pharma to Participate in September Investor Conferences

Aug 21, 2024, 8:00 AM EDT - 11 months ago

aTyr Pharma to Participate in September Investor Conferences


aTyr Pharma, Inc. (LIFE) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 11:37 PM EDT - 1 year ago

aTyr Pharma, Inc. (LIFE) Q4 2023 Earnings Call Transcript


aTyr Pharma to Present at November Investor Conferences

Nov 1, 2023, 8:00 AM EDT - 1 year ago

aTyr Pharma to Present at November Investor Conferences


aTyr Pharma, Inc. (LIFE) Q4 2022 Earnings Call Transcript

Mar 10, 2023, 5:12 PM EST - 2 years ago

aTyr Pharma, Inc. (LIFE) Q4 2022 Earnings Call Transcript


aTyr Pharma to Present at March Investor Conferences

Mar 8, 2023, 8:00 AM EST - 2 years ago

aTyr Pharma to Present at March Investor Conferences


Unknown_Stuntman
Unknown_Stuntman Jul. 7 at 4:53 PM
$ATYR wild volatility today
0 · Reply
Pratik2024
Pratik2024 Jul. 7 at 1:32 PM
$ATYR $GOOS $MWYN $PUBM $WRBY Good morning
0 · Reply
BioBingo
BioBingo Jul. 7 at 1:10 PM
$ATYR – What’s On This Week: Options Expiry Approaches, “Lab Conditions” Continue, and the Three-Month Countdown We’re entering the first full trading week of July, with $ATYR now within the three-month window for the pivotal Phase 3 efzofitimod readout. This week is shaping up as classic “lab conditions”: no major news, low volatility, and a calm tape post-Russell rebalance. Next short interest report drops later this week; options expiry (July 18) is fast approaching and could drive near-term positioning and volatility. Retail sentiment and engagement remain high. In my view, there’s no new info to change anyone’s core thesis—this is a period to observe, recalibrate, and prep for what’s ahead. Full long-form breakdown here: https://www.reddit.com/r/ATYR_Alpha/s/CjDzvXXBfh
0 · Reply
lola269
lola269 Jul. 7 at 12:17 PM
0 · Reply
bob397
bob397 Jul. 5 at 3:54 PM
1 · Reply
bob397
bob397 Jul. 5 at 3:52 PM
0 · Reply
xersdave
xersdave Jul. 5 at 12:54 PM
$ATYR Gimme that E-$40. SPRINKLE me.
0 · Reply
Passaten
Passaten Jul. 3 at 8:10 PM
$ATYR considering how much of the shares are locked up, this stock is one of the easiest right now to “press button, get money” 😂 just gotta be careful
0 · Reply
Unknown_Stuntman
Unknown_Stuntman Jul. 3 at 7:04 PM
$ATYR who would have thought this would turn into such a profitable day trade vehicle?
1 · Reply
RICARDO34
RICARDO34 Jul. 3 at 4:13 PM
$ATYR under accumulation at these levels. very promising
0 · Reply
xersdave
xersdave Jul. 3 at 12:17 PM
$ATYR Spread the word to your homies. Let’s get this MF STACKED.
1 · Reply
DonCorleone77
DonCorleone77 Jul. 3 at 10:53 AM
$ATYR Information regarding Wells Fargo analyst report on ATYR issued today: https://x.com/CorleoneDon77/status/1940723846606184950
1 · Reply
Pratik2024
Pratik2024 Jul. 2 at 8:28 PM
$ATYR $GOOS $MWYN $PUBM $WRBY MWYN $1.64 to $2.3 last week, then back to $1.64!! Loading time for another biggy move.
0 · Reply
OriginalTradeonrumor
OriginalTradeonrumor Jul. 2 at 7:00 PM
$ATYR as I explicitly stated, we will be jn this consolidated range of upper 4’s to 5.30’s for a bit and no surprise here we been🙂 While we wait for a surge higher out of this range ( which IMO will come prior to readout)…it amazes me how some people who supposedly have a bunch of money tied up here are trying to search for solice in posts If you have significant money in this or any stock you better have done a hell of a lot of homework way beyond posts! Anyway..not my circus not my clowns 😁 With that said Bio thanks for the informative posts …they are teaching a ton of people about market dynamics ..valuable stuff For all ….buy on the dips and hold for the surge!🙂 Let’s see what happens!
1 · Reply
Woodpecker99
Woodpecker99 Jul. 2 at 3:27 PM
$ATYR this thing doesn’t move much huh
6 · Reply
Lloyd03
Lloyd03 Jul. 2 at 2:21 PM
0 · Reply
__Godzilla__
__Godzilla__ Jun. 30 at 9:03 PM
$ATYR I am bullish on ATYR, but a couple of related thoughts. 1) The fact that any company (not picking on ATYR here) can be added to the Russell 2000 and Russell 3000 before it has shown to have a viable product is absurd. I know that both indexes are cap weighted and ATYR's affect is miniscule, but ATYR's inclusion is premature. 2) ATYR's inclusion means it joins the 40% of R2000 companies that won't make a profit in 2025. If you need a good reason not to own a R2000 or R3000 index fund or index ETF, then this is it. I would rather pay an active manager to select companies that make money than own the 40% that don't.
4 · Reply
BioBingo
BioBingo Jun. 30 at 8:06 PM
$ATYR – Cantor Roadshow Announced for July 30–31: Reading Between the Lines https://www.reddit.com/r/ATYR_Alpha/s/fSJVI2WWdB Cantor Fitzgerald will host a two-day Non-Deal Roadshow with aTyr Pharma ($ATYR) on July 30 (Denver, in-person) and July 31 (virtual), featuring CEO Sanjay Shukla and CFO Jill Broadfoot. On its surface, this might seem like standard IR. But the timing — which coincides with the listed primary completion date for aTyr’s Phase 3 trial — strongly suggests management has already seen the top-line data and is moving proactively to frame the story for institutions. This isn’t just a check-in. It’s likely a strategic narrative move: prepping key funds ahead of the readout and shaping how the results will be interpreted. If you’re watching $ATYR, this is worth your attention. Full analysis at the link.
2 · Reply
Hereinbama35
Hereinbama35 Jun. 30 at 4:09 PM
$ATYR This girl is playing with my feelings.
2 · Reply
BioBingo
BioBingo Jun. 30 at 12:18 PM
$ATYR – What’s On This Week: Post-Expiry Flows, Russell Rebalance, and Structural Positioning Just dropped an update for this week’s $ATYR setup, with a focus on what’s happening after the Russell rebalance, the latest options expiry, and why market structure matters so much right now. With no big catalysts, earnings, or filings on deck, we’re entering one of the quietest stretches in a while—prime time to observe tape behavior, track block trades, and spot any stealthy accumulation. I also share some new stats from my ongoing analysis of all 126 new Russell additions, plus details about the upcoming biotech training series for anyone wanting to level up. Community just hit 750+ members in under 7 weeks—appreciate the support! Full post here: https://www.reddit.com/r/ATYR_Alpha/s/MT4w9GVRGl
0 · Reply
Passaten
Passaten Jun. 30 at 2:49 AM
$ATYR TO THE MOON
0 · Reply
BioBingo
BioBingo Jun. 30 at 1:11 AM
$ATYR - The Russell Index Rebalance: The Game Behind the Game Friday 27 June was the wildest day yet for $ATYR: nearly 15.7M shares traded as it joined the Russell 2000 & 3000, yet the price barely moved. How does that happen when trillions in assets have to buy? It’s not just about volume—it’s about who’s really in control. I break down exactly how indexers, arbs, market makers, and shorts orchestrate these moves, why retail gets whipsawed, and what it means for future price action. The float is tighter, the game has changed, and if you want to level up as a retail investor, understanding the mechanics is now non-negotiable. Full deep-dive here: https://www.reddit.com/r/ATYR_Alpha/s/LXmQSF0K75
0 · Reply